What is it about?
Cell metabolism is documented in kidney disease, and our findings shows WWP2 regulates kidney fibrosis and mediates the metabolic reprogramming of profibrotic myofibroblasts. It provides new target for clinical translation for CKD.
Featured Image
Read the Original
This page is a summary of: WWP2 Regulates Kidney Fibrosis and the Metabolic Reprogramming of Profibrotic Myofibroblasts, Journal of the American Society of Nephrology, March 2024, Wolters Kluwer Health,
DOI: 10.1681/asn.0000000000000328.
You can read the full text:
Contributors
Be the first to contribute to this page
